Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 45.17
-0.08 (-0.18%)
Aug 1, 2025, 3:47 PM AEST
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Moderna stock at 2.88%, Incyte at 2.75%, Alnylam Pharmaceuticals at 2.71%, Halozyme Therapeutics at 2.68%, and Neurocrine Biosciences at 2.64%.
Total Holdings
10
Top 10 Percentage
26.64%
Asset Class
Equity
ETF Category
Health Care
Assets
30.98M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 2.88% |
| 2 | INCY | Incyte Corporation | 2.75% |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.71% |
| 4 | HALO | Halozyme Therapeutics, Inc. | 2.68% |
| 5 | NBIX | Neurocrine Biosciences, Inc. | 2.64% |
| 6 | UTHR | United Therapeutics Corporation | 2.63% |
| 7 | REGN | Regeneron Pharmaceuticals, Inc. | 2.63% |
| 8 | INSM | Insmed Incorporated | 2.62% |
| 9 | GILD | Gilead Sciences, Inc. | 2.56% |
| 10 | AMGN | Amgen Inc. | 2.54% |
As of Jul 30, 2025